PACS software drives ISG's growth
ISG Technologies continues to move forward from its proxy fight of a year ago. The Mississauga, Ontario-based medical imaging software developer reported an 8% increase in revenue for its 1998 fiscal first quarter, bringing sales to a company record for
ISG Technologies continues to move forward from its proxy fight of a year ago. The Mississauga, Ontario-based medical imaging software developer reported an 8% increase in revenue for its 1998 fiscal first quarter, bringing sales to a company record for the period.
ISG reported revenues of $5.8 million (U.S.) for the period (end-September), compared with $5.4 million in the first quarter of 1997. Net income was $6400, compared with a net loss of $780,000 in the same period last year. No extraordinary charges were reported during the quarter. The company increased its backlog during the period by more than $6.3 million, representing multiyear agreements for licensed software and contract engineering work, according to the firm.
While revenues from the company's image-guided surgery line were down significantly, substantial gains in sales of ISG's Viewing and Reading Station (VRS) PACS software offset the loss, resulting in overall flat revenues of $2.8 million for the company's licensed software efforts. Contract R&D revenues rose 48% to $2.8 million.
The company also reported favorable developments in its IAP medical imaging console software business. In other quarterly developments, ISG released a Windows NT version of its VRS product line. Previously, VRS was based exclusively on the Unix operating system.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Ultrasound-Guided Thermal Ablation Shows Low Recurrence of Thyroid Carcinoma at Five Years
June 16th 2025In a meta-analysis involving over 2,200 patients with T1NoMo papillary thyroid carcinoma, researchers noted 2 percent recurrence and no cases of lymph node metastasis five years after ultrasound-guided thermal ablation.
